Koyfin Home > Directory > Health Care > Amphastar Pharma > Gross Margin

Amphastar Pharma Gross Margin Chart (AMPH)

Amphastar Pharma annual/quarterly Gross Margin from 2014 to 2018. Gross margin is a company's total sales revenue minus its cost of goods sold (COGS), divided by total sales revenue, expressed as a percentage. The higher the percentage, the more the company retains on each dollar of sales, to service its other costs and debt obligations.
  • Amphastar Pharma Gross Margin for the quarter ending December 12, 2018 was $39m a 24.13% increase of 9m year over year
  • Amphastar Pharma Gross Margin for the last 12 months ending December 12, 2018 was $36m a 3.10% increase of 1m year over year
  • Amphastar Pharma Annual Gross Margin for 2018 was $36m a -4.12% decrease of -1m from 2017
  • Amphastar Pharma Annual Gross Margin for 2017 was $38m a -8.01% decrease of -3m from 2016
  • Amphastar Pharma Annual Gross Margin for 2016 was $41m a 24.69% increase of 10m from 2015
Other Margins & Efficiency Metrics:
  • Amphastar Pharma EBITDA Margin for the quarter ending December 12, 2018 was $6m a 248.20% increase of 16m year over year
  • Amphastar Pharma Return on Capital % for the quarter ending December 12, 2018 was 0.96 a 742.79% increase of 7.11 year over year
  • Amphastar Pharma Return on Equity % for the quarter ending December 12, 2018 was 1.95 a 547.96% increase of 10.67 year over year
View Chart On Koyfin

Quarterly AMPH Gross Margin Data

12/2018$39m
09/2018$39m
06/2018$37m
03/2018$29m
12/2017$34m
09/2017$35m
06/2017$41m
03/2017$40m
12/2016$31m
09/2016$43m

Annual AMPH Gross Margin Data

2018$36m
2017$38m
2016$41m
2015$31m
2014$24m
2013$38m